Tizanidine Tablet
Product Images NDC 63629-2371

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 63629-2371). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

Chemical structure of the active ingredient Tizanidine, showing its molecular components including chlorine (Cl), nitrogen (N), sulfur (S), and hydrochloride (HCl) groups as part of its chemical composition.*

FDA Label Image

Tizanidine-2 (Tizanidine 2)

A line graph displaying plasma Tizanidine concentration (ng/ml) over time in hours after dosing. The graph compares four conditions: 2 x 4 mg Tizanidine tablets with food, 2 x 4 mg tablets without food, 2 x 4 mg capsules with food, and 2 x 4 mg capsules without food. Concentration peaks within 2 hours and declines by 24 hours.*

FDA Label Image

Tizanidine-3 (Tizanidine 3)

A line graph showing improvement in Ashworth Score over time in hours post-dose for 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The vertical axis represents improvement scores, and the horizontal axis represents time from 0 to 6 hours post-dose. Error bars indicate variability in the measurements.*

FDA Label Image

Tizanidine-4 (Tizanidine 4)

A chart depicting improvement in Ashworth Score over time comparing tizanidine at a mean dose of 28.8 mg and placebo. The x-axis shows time points: End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward). The y-axis measures improvement in Ashworth Score from 2 to -6, with tizanidine showing greater improvement (lower scores) compared to placebo at all time points.*

FDA Label Image

Label (Lbl636292371)

Tizanidine Tablets USP 4 mg oral tablets label by Bryant Ranch Prepack. The label displays the NDC 63629-2371-1 and instructions for storage at 20° to 25°C. It states each tablet contains 4 mg of tizanidine base, equivalent to 4.567 mg tizanidine HCl. The package size is 1000 tablets, with dispensing in child-resistant containers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.